Showing results (21-30 of 141) with videos related to

Sort By:
Pageof 15
European Journal of Immunology|October 30, 2008
IL-4 inhibits VLA-4 expression on Tc1 cells resulting in poor tumor infiltration and reduced therapy benefitKotaro Sasaki, Angela D Pardee, Hideho Okada, et al.
Frontiers in Immunology|March 22, 2021
Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure FormationDeepak Salem, Manoj Chelvanambi, Walter J Storkus, et al.
Cancer Research|September 17, 2005
Nitric oxide sensitizes tumor cells to dendritic cell-mediated apoptosis, uptake, and cross-presentationJian Huang, Tomohide Tatsumi, Eva Pizzoferrato, et al.
Open Access Journal of Urology|November 8, 2013
Update on vaccine development for renal cell cancerNina Chi, Jodi K Maranchie, Leonard J Appleman, et al.
Frontiers in Immunology|December 19, 2013
Therapeutic use of dendritic cells to promote the extranodal priming of anti-tumor immunityLu Chen, Kellsye L Fabian, Jennifer L Taylor, et al.
Journal for Immunotherapy of Cancer|February 2, 2021
STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironmentManoj Chelvanambi, Ronald J Fecek, Jennifer L Taylor, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 2, 2007
Polarized type-1 dendritic cells (DC1) producing high levels of IL-12 family members rescue patient TH1-type antimelanoma CD4+ T cell responses in vitroAmy Wesa, Pawel Kalinski, John M Kirkwood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
A mycoplasma peptide elicits heteroclitic CD4+ T cell responses against tumor antigen MAGE-A6Lazar Vujanovic, Maja Mandic, Walter C Olson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 5, 2012
Combined Tbet and IL12 gene therapy elicits and recruits superior antitumor immunity in vivoYanyan Qu, Lu Chen, Devin B Lowe, et al.
Pageof 15